The findings should lead to changes in practice, David Cohen says, but as seen in the setting of PCI, “old habits die hard.” ...

PARIS, France—There is more than a twofold greater risk of death, and a significantly increased risk of major adverse cardiac events, over nearly 2 years of follow-up when patients with a bicuspid ...

In mostly women with small aortic annuli, self-expanding valves maintained superior hemodynamics and far lower valve ...

The introduction of transcatheter aortic valve implantation (TAVI) has substantially changed the treatment of aortic stenosis in high-risk surgical patients in the past 10 years Problems with the ...

Thubrikar Aortic Valve, Inc. today announced its partnership with MAC’s MEDICAL Group, a distributor of cardiovascular devices in Europe, and MAC’s CEO, Ante Cicin-Sain. As part of the exclusive ...

Clinical suitability is the primary requirement for selection of a patient for TAVI. Although TAVI compares favorably to conservative treatment in patients at high risk of or inoperable by ...

Abbott is now entering a corner of the medical device space that has been dominated by Edwards Lifesciences and Medtronic. On Tuesday, the company earned FDA approval for its latest transcatheter ...